On 15–16 June 2023, healthcare professionals and breast cancer patients and advocates from across Canada met in Toronto, Ontario, for the 2023 Canadian Breast Cancer Symposium (CBSC). The CBSC is a national, multidisciplinary event that occurs every 2 years with the goal of developing a personalized approach to the management of breast cancer in Canada. Experts provided state-of-the-art information to help optimally manage breast cancer patients, including etiology, prevention, diagnosis, experimental biology, and therapy of breast cancer and premalignant breast disease. The symposium also had the objectives of increasing communication and collaboration among breast cancer healthcare providers nationwide and providing a comprehensive and real-life review of the many facets of breast cancer. The sessions covered the patient voice, the top breast cancer papers from different disciplines in 2022, artificial intelligence in breast cancer, systemic therapy updates, the management of central nervous system metastases, multidisciplinary management of ductal carcinoma in situ, special populations, optimization-based individual prognostic factors, toxicity management of novel therapeutics, survivorship, and updates in surgical oncology. The key takeaways of these sessions have been summarized in this conference report.

中文翻译：

---

加拿大乳腺癌研讨会 2023 年会议报告

2023 年 6 月 15 日至 16 日，来自加拿大各地的医疗保健专业人员、乳腺癌患者和倡导者齐聚安大略省多伦多，参加 2023 年加拿大乳腺癌研讨会 (CBSC)。 CBSC 是一项全国性的多学科活动，每两年举办一次，其目标是在加拿大制定个性化的乳腺癌管理方法。专家们提供了最先进的信息，以帮助最佳地管理乳腺癌患者，包括乳腺癌和癌前乳腺疾病的病因学、预防、诊断、实验生物学以及治疗。研讨会的目标还在于加强全国乳腺癌医疗保健提供者之间的沟通与合作，并对乳腺癌的许多方面进行全面、真实的回顾。会议内容涵盖患者心声、2022年不同学科顶级乳腺癌论文、乳腺癌人工智能、系统治疗更新、中枢神经系统转移的管理、导管原位癌的多学科管理、特殊人群、基于优化的治疗等。个体预后因素、新疗法的毒性管理、生存率和外科肿瘤学的更新。本次会议报告总结了这些会议的主要内容。